Asosiy kontentga oʻtish
Maqola

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Joshua A WelshISEV Board 2020-2022Deborah C. I. GoberdhanISEV Board 2022-2024Lorraine O’DriscollISEV Board 2020-2022Edit I. BuzásHCEMM‐SU Extracellular Vesicle Research Group Semmelweis University Budapest HungaryCherie BlenkironFaculty of Medical and Health Sciences, The University of Auckland, Auckland, New ZealandBenedetta BussolatiDepartment of Molecular Biotechnology and Health Sciences University of Turin Turin ItalyHoujian CaiUniversity of Georgia Athens Georgia USADolores Di VizioISEV Board 2020-2022Tom A. P. DriedonksDepartment CDL Research University Medical Center Utrecht Utrecht The NetherlandsUta ErdbrüggerOriginal section drafting contributionJuan Manuel Falcón‐PérezExosomes Laboratory, Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance, Derio, SpainQing‐Ling FuExtracellular Vesicle Research and Clinical Translational Center The First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaAndrew F. HillISEV Board 2020-2022Metka LenassiISEV Board 2020-2022Sai Kiang LimDepartment of Surgery, YLL School of Medicine National University Singapore Singapore SingaporeMỹ G. MahoneyThomas Jefferson University Philadelphia Pennsylvania USASujata MohantyISEV Board 2022-2024Andreas MöllerISEV Board 2022-2024Rienk NieuwlandAmsterdam Vesicle Center, Amsterdam University Medical Centers, Location AMC University of Amsterdam Amsterdam The NetherlandsTakahiro OchiyaISEV Board 2020-2022Susmita SahooIcahn School of Medicine at Mount Sinai New York New York USAAna Cláudia TorrecilhasISEV Board 2022-2024Lei ZhengISEV Board 2020-2022Andries ZijlstraDepartment of Pathology Vanderbilt University Medical Center Nashville Tennessee USASarah AbuelreichOriginal section drafting contributionReem BagabasDepartment of Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USAPaolo BergeseCenter for Colloid and Surface Science (CSGI) Florence ItalyEsther BridgesWeatherall Institute of Molecular Medicine, University of Oxford, Oxford, UKMarco BrucaleConsiglio Nazionale delle Ricerche - Istituto per lo Studio dei Materiali Nanostrutturati, Bologna, ItalyDylan BurgerDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, CanadaRandy P. CarneyOriginal section drafting contributionEmanuele CocucciDivision of Pharmaceutics and Pharmacology, College of Pharmacy The Ohio State University Columbus Ohio USARossella CrescitelliSahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences Sahlgrenska Academy, University of Gothenburg Gothenburg SwedenEdveena HanserDepartment of Biomedicine University Hospital Basel Basel SwitzerlandAdrian L. HarrisDepartment of Oncology, University of Oxford, Oxford, UKNorman J. HaugheyDepartments of Neurology and Psychiatry Johns Hopkins University School of Medicine Baltimore Maryland USAAn HendrixCancer Research Institute Ghent Ghent BelgiumAlexander R. IvanovBarnett Institute of Chemical and Biological Analysis, Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USATijana Jovanović‐TalismanDepartment of Cancer Biology and Molecular Medicine, Beckman Research Institute City of Hope Comprehensive Cancer Center Duarte California USANicole A. Kruh‐GarciaBio‐pharmaceutical Manufacturing and Academic Resource Center (BioMARC) Infectious Disease Research Center, Colorado State University Fort Collins Colorado USAVroniqa Ku'ulei‐Lyn FaustinoOriginal section drafting contributionDiego KyburzDepartment of Biomedicine University of Basel Basel SwitzerlandCecilia LässerKrefting Research Centre, Department of Internal Medicine and Clinical Nutrition Institute of Medicine at Sahlgrenska Academy, University of Gothenburg Gothenburg SwedenKathleen M. LennonDepartment of Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California, USAJan LötvallKrefting Research Centre, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenAdam L. MaddoxOriginal section drafting contributionElena S. Martens‐UzunovaErasmus MC Cancer Institute University Medical Center Rotterdam, Department of Urology Rotterdam The NetherlandsRachel R. MizenkoOriginal section drafting contributionLauren A. NewmanCollege of Medicine and Public Health, Flinders University, Adelaide, AustraliaAndrea RidolfiDepartment of Physics and Astronomy, and LaserLaB Amsterdam Vrije Universiteit Amsterdam Amsterdam The NetherlandsEva RohdeTransfer Centre for Extracellular Vesicle Theralytic Technologies, EV-TT, Salzburg, AustriaTatu RojalinExpansion Therapeutics, Structural Biology and Biophysics Jupiter Florida USAAndrew RowlandOriginal section drafting contributionAndrás SafticsOriginal section drafting contributionUrsula S. SandauDepartment of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USAJulie A. SaugstadDepartment of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USAFaezeh ShekariCeler Diagnostics Toronto CanadaSimon SwiftOriginal section drafting contributionDmitry Ter‐OvanesyanWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USAJuan Pablo TosarUniversidad de la República Montevideo UruguayZivile UseckaiteCollege of Medicine and Public Health, Flinders University, Adelaide, AustraliaFrancesco ValleConsiglio Nazionale delle Ricerche ‐ Istituto per lo Studio dei Materiali Nanostrutturati Bologna ItalyZoltán VargaBiological Nanochemistry Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Budapest, HungaryEdwin van der PolLaboratory of Experimental Clinical Chemistry, Amsterdam UMC, location AMC University of Amsterdam Amsterdam The NetherlandsMartijn J. C. van HerwijnenDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The NetherlandsMarca H. M. WaubenDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine Utrecht University Utrecht The NetherlandsAnn M. WehmanOriginal section drafting contributionS WilliamsInternational Society for Extracellular VesiclesAndrea ZendriniDepartment of Molecular and Translational Medicine University of Brescia Brescia ItalyAlan ZimmermanOriginal section drafting contributionClotilde ThéryISEV Board 2020-2022Kenneth W. WitwerEV Core Facility “EXCEL”, Institute for Basic Biomedical Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA
2024en
Ochiq kirishOltin

Litsenziya: cc-by

ABI

Annotatsiya

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

11 ta iqtibos0 ta foydalanilgan manba